ADO

8.70%

2.1¢ anteotech ltd

Ann: FY2024 Full Year Results - Investor Presentation, page-64

First 64 Last

Share
Profile

Follow
Brickwalls

8,942 Posts.

1961

30/08/24

11:29

Post #: 75452880
Share

Originally posted by PeterFred: ↑

My major observation of this latest report and webinar, is of steady progress devoid of nasty surprises. A few highlights for me:

** a steady broadening of sales and therefore revenue opportunities;
** increasing revenues from services;
** substantial potential within India - consider the influence of the SII contract (and its potential expansion), and the professional network: how many Vidcares might emerge;
** EV1- very please it has moved into prototyping now, and on target to freeze by the end of this calendar year;
** EV2 - now defining projects (that had been scoped previously, I assume);
** EV3 - now scoping projects with them
** carbon nanotubes; sure, there business is threatened because adding AnteoX reduces the demand for50% or more of the nanotubes; do they fight us, or join with us to take a combined product to the market? The market then has to incorporate only one "ingredient" into the battery mix. I'd be very sure after the Ferroglobe case, that our agreements with nanotube companies will be tighter than that of the proverbial fish. And having the nanotube companies on board, broadens are market access.
** breadth in consumer electronics - eg, mobility projects (these are new);
** the biosecurity market potential - I wonder how large this might become, and I think our shellfish work with a government Fisheries Department may well spawn other projects; David speaks of a straightforward lateral flow "dipstick" implementation - seems like a winner.
** the new Marketing VP - if all goes well, evidently has a very good background in batteries, and will be a good cultural fit there in Europe.

Yes, a lot to like. I perceive a rising curve of revenues as more product is used; the word "parabolic" can be used emotionally, and that is not my intent - rather, to describe the shape of the revenue curve, over this next period. Of course, any move into mass-production for EVs and hybrids will step-change the parabola.

A good report and webinar: well-presented, and with confidence.

Expand

EV1 revenue timeline p21. -:- put in contex of Consumer Devices and Power Tools inferred timelines (from Diags p14 & p20).

>>>>> points to >>>>>> double-dip oppies >>>>>>> $MIL€ timeline.

ADO Price at posting: 2.2¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BUX

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 37 more messages in this thread...

First 64 Last

Add ADO (ASX) to my watchlist

(20min delay)
Last 2.1¢		Change -0.002(8.70%)		Mkt cap ! $52.28M

Open	High	Low	Value	Volume
2.2¢	2.2¢	2.1¢	$20.83K	964.6K

Buyers (Bids)

No.	Vol.	Price($)
4	2247357	2.1¢

Sellers (Offers)

Price($)	Vol.	No.
2.2¢	164375	3

View Market Depth

No.	Vol.	Price($)
2	739397	0.021
9	1445497	0.020
10	2127381	0.019
4	1601447	0.018
3	1564748	0.017

Price($)	Vol.	No.
0.023	642868	9
0.024	741966	3
0.025	478846	7
0.026	83915	2
0.027	250000	1

Last trade - 16.10pm 04/10/2024 (20 minute delay)

ADO (ASX) Chart

Ann: FY2024 Full Year Results - Investor Presentation, page-64

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI reaches close of funding facility for salt-first part of Mardie project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: FY2024 Full Year Results - Investor Presentation, page-64

Top Stories

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI reaches close of funding facility for salt-first part of Mardie project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News